Articles From: F5 Announces Date for Q2 Earnings Conference Call to 2012 Results to be Released on 18 March 2013


2013/3/13
F5 Networks, Inc. (NASDAQ: FFIV ), the global leader in Application Delivery Networking, today announced that company management will host a conference call to review financial results for the second quarter of fiscal year 2013 on April 24, 2013, at 1:30 p.m. PT.
Sign-up for F5 Announces Date for Q2 Earnings Conference Call investment picks
2013/3/13
Kopin Corporation (NASDAQ: KOPN) today announced financial results for the fourth quarter and fiscal year ended December 29, 2012.
Sign-up for Kopin Corporation Announces Wearable Computing Strategy and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 29, 2012 investment picks
2013/3/13
IceWEB, Inc. (OTC BB:IWEB) , an award-winning Unified Data Storage appliance provider for cloud and virtual environments that features highly secure, scalable IceBOX TM Private and Hybrid Cloud solutions announced today that it is planning to change its name to better reflect its new business model, and in anticipation of its upcoming acquisition of Computers and Tele-Comm, Inc. Subject to shareholder approval, the new company name will be Ximbus, Inc., a contraction of the acronym XIM (Extended Information Management) and Nimbus, the Latin word for cloud or halo.
Sign-up for IceWEB Plans Corporate Name Change to Ximbus, Inc. investment picks
2013/3/13
Fourth Quarter Financial Highlights - Total net service revenues of $63.8 million - Total net income of $3.7 million, or $0.35 per diluted share - The Company completed the sale of substantially all of the assets of its Home Health business effective on March 1, 2013 for $20 million cash and retained a ten percent interest in the business in Illinois and California.
Sign-up for Addus HomeCare Reports Fourth Quarter 2012 Results Completes Sale of Home Health Assets investment picks
2013/3/13
NEWARK, Del.
Sign-up for iBio Adds to iBioModulator Portfolio and Product Pipeline investment picks
2013/3/13
Verastem, Inc., (NASDAQ: VSTM) , a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that financial results for the year ended December 31, 2012, will be released before the market opens on Wednesday, March 27, 2013.
Sign-up for Verastem Announces Timing for Year-End 2012 Financial Results, Webcast and Conference Call investment picks
2013/3/13
Foster Wheeler AG (Nasdaq: FWLT) announced today that Scott Lamb, Vice President of Investor Relations and Corporate Communications, will participate in the BB&T Commercial and Industrial Conference in Coral Gables, Florida on Wednesday, March 20, 2013.
Sign-up for Foster Wheeler to Participate in BB&T Capital Markets Commercial and Industrial Conference investment picks
2013/3/13
EAST HARTFORD, Conn.
Sign-up for Pratt & Whitney, U.S. Air Force Complete First Depot Overhaul of an F119 Engine investment picks
2013/3/13
SAN DIEGO, Calif., March 13, 2013 (GLOBE NEWSWIRE) -- The Governance Institute, a service of National Research Corporation, partnered with the Jefferson School of Population Health (JSPH) to present a one-day training program on quality and safety for board members who attended The Governance Institute's Leadership Conference earlier this month at The Breakers in Palm Beach, FL.
Sign-up for New Governance Training Program in Quality and Safety investment picks
2013/3/13
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that it will release its financial results for fourth quarter and year ended December 31, 2012 on March 21, 2013.
Sign-up for Vertex Energy, Inc. to Release Year-End 2012 Financial Results on March 21, 2013 investment picks
2013/3/13
Acorda Therapeutics, Inc. (Nasdaq:  ACOR ) will present new research data at the 65 th American Academy of Neurology Annual Meeting on AMPYRA ®  (dalfampridine) Extended Release Tablets, 10 mg, an FDA-approved therapy indicated to improve walking in people with multiple sclerosis, and Diazepam Nasal Spray, an investigational therapy for the treatment of cluster seizures, also known as acute repetitive seizures, in people with epilepsy.
Sign-up for Acorda to Present New Research on Novel Multiple Sclerosis and Epilepsy Therapies at American Academy of Neurology 65th Annual Meeting investment picks
2013/3/13
BioLineRx (NASDAQ:BLRX) (TASE:BLRX), a biopharmaceutical development company, announced today that it has received approval from the French regulatory authorities to commence a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus (HCV). The study is an open-label trial to evaluate the efficacy, safety and tolerability of BL-8020 in patients infected with HCV.
Sign-up for BioLineRx Receives Approval from French Regulatory Authorities to Commence a Phase I/II Clinical Trial for BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C investment picks
2013/3/13
CHICAGO , March 13, 2013 /PRNewswire/ -- Business travel serves as an important barometer for overall economic outlook and sentiment, and consistent with Wall Street's strong first quarter, employers started out the year bullish with 74 percent of business travelers expecting the same amount or more business travel in 2013, compared to last year,according to a survey of business travelers conducted by the Newsweek & The Daily Beast research department in partnership with Orbitz for Business , the corporate travel brand of Orbitz Worldwide (NYSE: OWW) .
Sign-up for Robust Environment for Business Travel is Consistent with Overall Market Strength, According to Survey Fielded by Newsweek & The Daily Beast and Orbitz for Business investment picks
2013/3/13
Covidien (NYSE:COV) , a leading global provider of healthcare products, is launching three new hernia care products that address clinical needs in laparoscopic inguinal, ventral and umbilical hernia repair.
Sign-up for Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting investment picks
2013/3/13
RALEIGH, N.C. , March 13, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr.
Sign-up for BioDelivery Sciences to Present at the 25th Annual ROTH Conference investment picks
2013/3/13
AECOM Technology Corporation (NYSE: ACM) , a leading provider of professional technical and management support services for public and private clients in more than 140 countries around the world, announced today that a joint venture in which it participates was awarded an eight-year highways contract worth up to US$500 million by Transport for London to provide design and engineering services.
Sign-up for AECOM joint venture awarded contract worth up to US$500 million by Transport for London investment picks
2013/3/13
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the fourth quarter and full year ended December 31, 2012.
Sign-up for Antares Pharma Reports Fourth Quarter and Full Year 2012 Operating and Financial Results investment picks
2013/3/13
SAN DIEGO , March 13, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the completion of enrollment in its double-blind Phase 2 clinical study of CERE-110 (AAV-NGF), a gene therapy product designed to deliver nerve growth factor (NGF) for the treatment of Alzheimer's disease.
Sign-up for Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial investment picks
2013/3/13
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=995939&ProfileId=051205&sourceType=1 SEAL BEACH, CA --
Sign-up for Independence Energy Advances Discussions With Local Oil and Gas Operators in Texas investment picks
2013/3/13
Global data center services provider CyrusOne (NASDAQ: CONE) and Infinera (NASDAQ: INFN) announced today their partnership on CyrusOne's Texas Internet Exchange (IX), the first statewide IX in the United States.
Sign-up for Global Data Center Solutions Provider CyrusOne Partners with Infinera to Deploy High-Speed Cloud-Based Services in Texas investment picks
2013/3/13
COM DEV International Renews Normal Course Issuer Bid Canada NewsWire COM DEV International Ltd.
Sign-up for COM DEV International Renews Normal Course Issuer Bid investment picks
2013/3/13
Broadwind Energy, Inc. (NASDAQ: BWEN) today announced that Peter Duprey, CEO, and Stephanie Kushner, CFO, will present at Roth Capital Partners’ 25 th Annual Growth Stock Conference in Dana Point, CA on Wednesday, March 20, 2013 at 11:00 a.m. local time.
Sign-up for Broadwind Energy to Present at Roth Capital Partners 25th Annual Growth Stock Conference investment picks
2013/3/13
http://media.marketwire.com/attachments/200811/432392_conmed.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=995870&ProfileId=051205&sourceType=1 UTICA, NY --
Sign-up for CONMED Corporation to Present at the 2013 Canaccord Genuity Musculoskeletal Conference investment picks
2013/3/13
DENVER , March 13, 2013 /PRNewswire/ -- Resolute Energy Corporation (the "Company" or "Resolute") (NYSE: REN) announced today that it has commenced a registered exchange offer (the "Exchange Offer") to exchange up to $400,000,000 aggregate principal amount of its 8.50% Senior Notes due 2020 which have been registered under the Securities Act of 1933, as amended (the "Exchange Notes"), for up to $400,000,000 of its outstanding 8.50% Senior Notes due 2020, which were issued on April 25, 2012 and December 10, 2012 in two separate private placements (the "Old Notes"). The sole purpose of the Exchange Offer is to fulfill the Company's obligations pursuant to exchange and registration rights agreements entered into by the Company in connection with the sales of the Old Notes.
Sign-up for Resolute Energy Corporation Announces Exchange Offer investment picks
2013/3/13
PENNINGTON, N.J., March 13, 2013 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (Nasdaq:OPTT) ("OPT" or "the Company"), a leading wave energy technology company, today announced that it will participate in the 25th Annual Roth Capital Conference on March 20, 2013 at the Ritz-Carlton in Laguna Niguel, CA.
Sign-up for Ocean Power Technologies to Present at the 25th Annual Roth Capital Conference in California on March 20, 2013 investment picks
2013/3/13
SOUTH SAN FRANCISCO, Calif., March 13, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the fourth quarter and year ended December 31, 2012.
Sign-up for Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights investment picks
2013/3/13
- Fourth quarter comparable sales increase by 1.5% - Fourth quarter diluted EPS of $0.75, exceeds upper end of increased guidance - Inventory per square foot decreases 6.0% - 15 international franchise locations at year end COLUMBUS, Ohio , March 13, 2013 /PRNewswire/ -- Express, Inc. (NYSE: EXPR) , a specialty retail apparel chain operating more than 620 stores, today announced fourth quarter and full year 2012 financial results for the fourteen and fifty-three week periods ended February 2 , 2013.
Sign-up for Express, Inc. Reports Fourth Quarter And Full Year 2012 Results; Introduces First Quarter And Full Year 2013 Outlook investment picks
2013/3/13
Award To Be Presented By The Famous Rick's Cabaret Girls NEW YORK CITY , March 13, 2013 /PRNewswire/ -- The  Rick's Cabaret New York  Girls will present sultry adult film star Tabitha Stevens with the first ever " Sexiest Podcast " award Tuesday March 19th , 8PM , at the upscale gentlemen's club at 50 West 33 rd St., across from the Empire State Building and just down the street from Madison Square Garden .
Sign-up for Hall Of Fame Adult Film Star Tabitha Stevens To Receive "Sexiest Podcast" Award At Rick's Cabaret New York, Tuesday, March 19th, 8pm investment picks
2013/3/13
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996166&ProfileId=051205&sourceType=1 AMSTERDAM, THE NETHERLANDS --
Sign-up for 2012 Results to be Released on 18 March 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: F5 Announces Date for Q2 Earnings Conference Call to 2012 Results to be Released on 18 March 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity